Document Detail

Effectiveness of Amlodipine-Valsartan Single-Pill Combinations: Hierarchical Modeling of Blood Pressure and Total Cardiovascular Disease Risk Outcomes (the EXCELLENT Study).
MedLine Citation:
PMID:  21666094     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Both patient- and physician-related factors have been shown to explain variability in the outcomes of antihypertensive treatment. Total cardiovascular risk (TCVR) is increasingly used as a determinant of treatment effectiveness but has also been proposed as a treatment outcome. To our knowledge, no studies have reported how antihypertensive treatment impacts blood pressure and TCVR outcomes.
OBJECTIVE: To examine in patients treated with a regimen including single-pill combinations (SPCs) of amlodipine/valsartan (1) blood pressure (BP) reduction and control, total cardiovascular risk (TCVR) change, and TCVR reduction of 1 class or more; (2) hierarchical patient- and physician-level determinants of these outcomes; and (3) predictors of uncontrolled BP and improved TCVR classification.
METHODS: A prospective (90 days), multicenter, multilevel pharmacoepidemiologic study was conducted in 3546 patients with hypertension treated with SPC amlodipine/valsartan by 698 general practitioners. Statistical analysis included hierarchical linear and logistic modeling of BP and TCVR outcomes.
RESULTS: Mean (SD) systolic BP (SBP) reductions were 20.1 (15.5) mm Hg and diastolic BP (DBP) reductions were 9.8 (10.3) mm Hg, with higher reductions among high-risk patients. SBP, DBP, and SBP/DBP control rates were 33.3%, 45.3%, and 25.5%, respectively, with lower rates among high-risk patients. Mean TCVR improvement was a reduction of 0.73 (0.96) classes (-4 [best] to +4 [worst]), with higher reductions for high-risk patients; 58.2% of patients achieved a TCVR reduction of 1 or more classes, with lower percentages for high-risk patients. Twenty-two percent of systolic variability and 26% of diastolic variability in 90-day BP values were attributable to a physician class effect, as was 16% of TCVR change.
CONCLUSIONS: Regimens that include SPC amlodipine/valsartan formulations are effective in reducing BP and TCVR in a real-world observational setting. Hierarchical modeling identified patient- and physician-related determinants of BP values and TCVR change, as well as independent predictors of uncontrolled BP and reduced TCVR. TCVR is a scientifically feasible and clinically relevant effectiveness outcome of antihypertensive treatment.
Robert Lins; Ann Aerts; Nicolas Coen; Christine Hermans; Karen Macdonald; Heidi Brié; Christopher Lee; Yu-Ming Shen; Stefaan Vancayzeele; Natalie Mecum; Ivo Abraham
Related Documents :
6696084 - Changes in smooth muscle tone influence characteristic impedance of the aorta.
21827664 - Antihypertensive and antioxidant effects of dietary black sesame meal in pre-hypertensi...
6519764 - Effect of raised portal venous pressure on blood pressure, urine output and body fluids.
21803464 - A model of systolic blood pressure during the course of dialysis and clinical factors a...
8207364 - A 5-year prospective, observational study of the withdrawal of antihypertensive treatme...
12242584 - Relationship between diet and blood pressure in a representative mediterranean population.
Publication Detail:
Type:  Journal Article     Date:  2011-06-10
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  45     ISSN:  1542-6270     ISO Abbreviation:  Ann Pharmacother     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-06-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  727-39     Citation Subset:  IM    
, Faculty of Medicine, University of Antwerp and Clinician, Division of Nephrology and Hypertension, ZNA Stuivenberg, Antwerpen, Belgium; Managing SGS Life Science Services, Mechelen, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Methadone Toxicity Due to Smoking Cessation--A Case Report on the Drug-Drug Interaction Involving Cy...
Next Document:  High-dose dexmedetomidine for sedation in the intensive care unit: an evaluation of clinical efficac...